GG
GSK icon

Gleason Group’s GSK GSK Stock Holding History

Gleason Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.83K Buy
+73
New +$3.86K ﹤0.01% 366
2023
Q4 		– Sell
-12,217
Closed -$443K – 226
2023
Q3 		$443K Buy
12,217
+123
+1% +$4.37K 0.12% 49
2023
Q2 		$431K Buy
12,094
+106
+0.9% +$3.8K 0.11% 53
2023
Q1 		$427K Buy
11,988
+110
+0.9% +$3.85K 0.12% 52
2022
Q4 		$417K Buy
11,878
+140
+1% +$4.66K 0.13% 53
2022
Q3 		$345K Buy
11,738
+90
+0.8% +$3.41K 0.12% 48
2022
Q2 		$634K Buy
11,648
+148
+1% +$8.17K 0.22% 39
2022
Q1 		$626K Buy
11,500
+127
+1% +$6.9K 0.19% 40
2021
Q4 		$627K Buy
11,373
+147
+1% +$7.65K 0.2% 42
2021
Q3 		$536K Buy
11,226
+144
+1% +$7.23K 0.19% 47
2021
Q2 		$552K Buy
11,082
+188
+2% +$9.03K 0.2% 44
2021
Q1 		$486K Buy
10,894
+1,327
+14% +$60.2K 0.19% 45
2020
Q4 		$440K Buy
9,567
+121
+1% +$5.56K 0.21% 45
2020
Q3 		$444K Buy
9,446
+109
+1% +$5.46K 0.26% 44
2020
Q2 		$476K Buy
9,337
+133
+1% +$6.82K 0.29% 38
2020
Q1 		$436K Buy
9,204
+96
+1% +$5.12K 0.35% 35
2019
Q4 		$535K Buy
+9,108
New +$507K 0.32% 39

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Gleason Group's GSK Position: Q2 2026 in Review

Gleason Group opened a new position in GSK (GSK) in Q2 2026: 73 shares worth $3.83K. The stake represents ﹤0.01% of the portfolio and ranks #366 among its holdings. This is a return to the name: Gleason Group previously reported a position in GSK as recently as Q3 2023.

Gleason Group first reported a position in GSK in Q4 2019 and has held it in 17 quarters since. The position peaked at $634K in Q2 2022. 1,038 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Gleason Group held 73 shares of GSK worth $3.83K as of Q2 2026.
  • GSK was a new Gleason Group position in Q2 2026.
  • GSK made up ﹤0.01% of Gleason Group's portfolio in Q2 2026, its #366 holding.
  • Gleason Group first reported a position in GSK in Q4 2019 and has held it in 17 quarters since.
  • Gleason Group's GSK position peaked at $634K in Q2 2022.
  • 1,038 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.